2008;155:284 9. 35. Marso SP, Miller T, Rutherford BD, et al. Comparison of myocardial reperfusion in patients undergoing percutaneous coronary interven- tion in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial). Am J Cardiol. 2007;100:206 10. 36. Timmer JR, van der Horst ICC, de Luca G, et al. Comparison of myocar- dial perfusion after successful primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction with versus without diabetes mellitus. Am J Cardiol. 2005;95:1375 7. 37. Alexander KP, Newby LK, Armstrong PW, et al. Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scien- tific statement for healthcare professionals from the American Heart Asso- ciation Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation. 2007;115:2570 89. 38. Alexander KP, Newby LK, Cannon CP, et al. Acute coronary care in the elderly, part I: non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the So- ciety of Geriatric Cardiology. Circulation. 2007;115:2549 69. 39. Michaels AD, Spinler SA, Leeper B, et al. Medication errors in acute car- diovascular and stroke patients: a scientific statement from the American Heart Association. Circulation. 2010;121:1664 82. 40. Shah P, Najafi AH, Panza JA, et al. Outcomes and quality of life in patients > or =85 years of age with ST-elevation myocardial infarction. Am J Car- diol. 2009;103:170 4. 41. Lewis WR, Ellrodt AG, Peterson E, et al. Trends in the use of evidence- based treatments for coronary artery disease among women and the el- derly: findings from the Get With The Guidelines Quality-Improvement Program. Circ Cardiovasc Qual Outcomes. 2009;2:633 41. 42. Herzog CA. Acute myocardial infarction in patients with end-stage renal disease. Kidney Int Suppl. 1999;71:S130 3. 43. 